Leisure Acquisition Corp. (LACQ) Shareholders Approve Ensysce Biosciences Deal
Leisure Acquisition Corp. (NASDAQ:LACQ) announced in an 8-K filing this morning that its shareholders approved its combination with clinical-stage biopharmaceutical company Ensysce Biosciences, Inc. at a special meeting yesterday.
Importantly, investors redeemed just 5,000 shares in connection with the vote and did so at a significant loss as Leisure’s shares traded above $13 throughout June 24, the SPAC’s redemption deadline. ...READ MORE
